Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.050 AUD
−19.94 M AUD
12.09 M AUD
244.64 M
About MICROBA LIFE SCIENCES LIMITED
Sector
Industry
CEO
Luke Reid
Website
Headquarters
Brisbane
Founded
2017
ISIN
AU0000209868
FIGI
BBG015D3N4T1
Microba Life Sciences Ltd. engages in the provision of microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. It operates through the Testing Services and Supplements and Research and Development segments. The company was founded by Gene Tyson and Philip Hugenholtz on January 31, 2017 and is headquartered in Brisbane, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MAP is 0.185 AUD — it has decreased by −2.63% in the past 24 hours. Watch MICROBA LIFE SCIENCES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MICROBA LIFE SCIENCES LIMITED stocks are traded under the ticker MAP.
MAP stock has risen by 2.78% compared to the previous week, the month change is a 12.12% rise, over the last year MICROBA LIFE SCIENCES LIMITED has showed a −7.50% decrease.
We've gathered analysts' opinions on MICROBA LIFE SCIENCES LIMITED future price: according to them, MAP price has a max estimate of 0.44 AUD and a min estimate of 0.33 AUD. Watch MAP chart and read a more detailed MICROBA LIFE SCIENCES LIMITED stock forecast: see what analysts think of MICROBA LIFE SCIENCES LIMITED and suggest that you do with its stocks.
MAP stock is 2.70% volatile and has beta coefficient of −1.13. Track MICROBA LIFE SCIENCES LIMITED stock price on the chart and check out the list of the most volatile stocks — is MICROBA LIFE SCIENCES LIMITED there?
Yes, you can track MICROBA LIFE SCIENCES LIMITED financials in yearly and quarterly reports right on TradingView.
MICROBA LIFE SCIENCES LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
MICROBA LIFE SCIENCES LIMITED revenue for the last half-year amounts to 8.80 M AUD, despite the estimated figure of 8.50 M AUD. In the next half-year revenue is expected to reach 8.10 M AUD.
MAP net income for the last half-year is −8.45 M AUD, while the previous report showed −11.49 M AUD of net income which accounts for 26.44% change. Track more MICROBA LIFE SCIENCES LIMITED financial stats to get the full picture.
No, MAP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROBA LIFE SCIENCES LIMITED EBITDA is −23.92 M AUD, and current EBITDA margin is −197.86%. See more stats in MICROBA LIFE SCIENCES LIMITED financial statements.
Like other stocks, MAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROBA LIFE SCIENCES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROBA LIFE SCIENCES LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROBA LIFE SCIENCES LIMITED stock shows the sell signal. See more of MICROBA LIFE SCIENCES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.